BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6420543)

  • 1. Blood vessel uptake and metabolism of organic nitrates in the rat.
    Fung HL; Sutton SC; Kamiya A
    J Pharmacol Exp Ther; 1984 Feb; 228(2):334-41. PubMed ID: 6420543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in vivo.
    Mülsch A; Bara A; Mordvintcev P; Vanin A; Busse R
    Br J Pharmacol; 1995 Nov; 116(6):2743-9. PubMed ID: 8590999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid microbial degradation of organic nitrates in rat excreta. Re-examination of the urinary and fecal metabolite profiles of pentaerythritol tetranitrate in the rat.
    King SY; Fung HL
    Drug Metab Dispos; 1984; 12(3):353-7. PubMed ID: 6145563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood and tissue levels of [14C]isosorbide dinitrate after oral and intravenous administration to rat.
    Reed DE; Akester JM; Prather JF; Tuckosh JR; McCurdy DH; Yeh C
    J Pharmacol Exp Ther; 1977 Jul; 202(1):32-7. PubMed ID: 874817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of ITF 296-induced vasorelaxation compared to nitroglycerin and isosorbide dinitrate: relationship between relaxation of rabbit aorta and tissue cGMP.
    Donà G; Giuliani P; Cremonesi P; Passaro A; Stella P; Tursi F; Mizrahi J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S59-66. PubMed ID: 8839228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac output is an apparent determinant of nitroglycerin pharmacokinetics in rats.
    Fung HL; Blei A; Chong S
    J Pharmacol Exp Ther; 1986 Dec; 239(3):701-5. PubMed ID: 3098960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the flavoprotein inhibitor, diphenyleneiodonium sulfate, on ex vivo organic nitrate tolerance in the rat.
    Ratz JD; McGuire JJ; Anderson DJ; Bennett BM
    J Pharmacol Exp Ther; 2000 May; 293(2):569-77. PubMed ID: 10773030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E deficiency accelerates nitrate tolerance via a decrease in cardiac P450 expression and increased oxidative stress.
    Minamiyama Y; Takemura S; Hai S; Suehiro S; Okada S
    Free Radic Biol Med; 2006 Mar; 40(5):808-16. PubMed ID: 16520233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and metabolism of nitroglycerin and its metabolites in vascular beds of sheep.
    Cossum PA; Roberts MS; Yong AC; Kilpatrick D
    J Pharmacol Exp Ther; 1986 Jun; 237(3):959-66. PubMed ID: 3086541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular peroxynitrite formation during organic nitrate tolerance.
    Mihm MJ; Coyle CM; Jing L; Bauer JA
    J Pharmacol Exp Ther; 1999 Oct; 291(1):194-8. PubMed ID: 10490904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSH-independent denitration of organic nitrate esters in rabbit hepatic and vascular cytosol.
    Ogawa N; Hirose T; Tsukamoto M; Fukushima K; Suwa T; Satoh T
    Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):153-61. PubMed ID: 7670847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific binding of nitroglycerin to coronary artery microsomes. Evidence of a vascular nitrate binding site.
    Bauer JA; Fung HL
    Biochem Pharmacol; 1996 Aug; 52(4):619-25. PubMed ID: 8759035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for the pharmacologic interaction of organic nitrates with thiols. Existence of an extracellular pathway for the reversal of nitrate vascular tolerance by N-acetylcysteine.
    Fung HL; Chong S; Kowaluk E; Hough K; Kakemi M
    J Pharmacol Exp Ther; 1988 May; 245(2):524-30. PubMed ID: 3130476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of organic nitrates.
    Fung HL
    Am J Cardiol; 1987 Nov; 60(15):4H-9H. PubMed ID: 3120565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance and metabolism of organic nitrates.
    Johnson EM; Harkey AB; Blehm DJ; Needleman P
    J Pharmacol Exp Ther; 1972 Jul; 182(1):56-62. PubMed ID: 4625289
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitrosothiol and nitrate tolerance.
    Fung HL; Poliszczuk R
    Z Kardiol; 1986; 75 Suppl 3():25-7. PubMed ID: 3099484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous administration of organic nitrate decreases hepatic cytochrome P450.
    Minamiyama Y; Takemura S; Yamasaki K; Hai S; Hirohashi K; Funae Y; Okada S
    J Pharmacol Exp Ther; 2004 Feb; 308(2):729-35. PubMed ID: 14593088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiol compounds and organic nitrates.
    Boesgaard S
    Dan Med Bull; 1995 Nov; 42(5):473-84. PubMed ID: 8747803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo nitrate tolerance is not associated with reduced bioconversion of nitroglycerin to nitric oxide.
    Laursen JB; Mülsch A; Boesgaard S; Mordvintcev P; Trautner S; Gruhn N; Nielsen-Kudsk JE; Busse R; Aldershvile J
    Circulation; 1996 Nov; 94(9):2241-7. PubMed ID: 8901678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of tissue thiols content from nitroglycerin-induced cyclic-3',5'-guanosine monophosphate and the state of tolerance: in vivo experiments in rats.
    Haj-Yehia AI; Benet LZ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):94-100. PubMed ID: 7714819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.